| Respiratory Syncytial Virus (RSV) Infection |
1 |
0.67 |
| Adverse Effects |
0 |
0.55 |
| Selective Serotonin-Reuptake Inhibitors |
0 |
0.5 |
| Patient Safety |
0 |
0.49 |
| Vaccines |
0 |
0.45 |
| Geriatrics |
0 |
0.44 |
| COVID-19 Vaccine |
0 |
0.37 |
| Depression |
0 |
0.36 |
| Gastroesophageal Reflux Disease |
0 |
0.35 |
| Receptors |
0 |
0.33 |
| Menopause |
0 |
0.32 |
| Major Depression |
0 |
0.24 |
| Antidepressant drug |
0 |
0.22 |
| Primary Care |
0 |
0.22 |
| Abdominal Pain |
0 |
0.19 |
| Abdomen |
0 |
0.11 |
| Anxiety |
0 |
0.11 |
| Brain |
0 |
0.11 |
| Child |
0 |
0.11 |
| Cognitive Behavioral Therapy |
0 |
0.11 |
| Esophagitis |
0 |
0.11 |
| Food and Drug Administration (FDA) |
0 |
0.11 |
| Hypnosis |
0 |
0.11 |
| Kidney |
0 |
0.11 |
| Pain |
0 |
0.11 |
| Pain Management |
0 |
0.11 |
| Proton Pump Inhibitor |
0 |
0.11 |
| Sexual Dysfunction |
0 |
0.11 |
| Shared Decision-Making |
0 |
0.11 |
| Insomnia |
0 |
0.09 |
| Sleep Disorders |
0 |
0.09 |
| Erosive Esophagitis |
0 |
0.06 |